{"id":"tp-33774","type":"article-newspaper","title":"Novartis Ends Phase 2 Fabhalta Trial for Lupus Kidney Disease","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/33774","datePublished":"2026-10-17T05:44:31.000Z","dateModified":"2026-10-17T05:44:31.000Z","language":"en","abstract":"In an Oct. 15 update, Novartis gave strategic considerations as the reason after Part 1’s final patient completed the last visit.","section":"Business","references":[]}